Shots: Endocyte to receive $24M/share in cash with total deal value of $2.1B. Novartis to get hold of all stocks with its RLT candidates Lu-PSMA-617 & Ac-PSMA-617 Lu-PSMA-617 is a […]readmore
Tags : Investigational Radioligand Therapy (RLT) Platform